U.S. FDA To Open India Office In December
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - U.S. FDA plans to step up scrutiny of drugs and food made in India for the U.S. market by setting up offices next month in the country after establishing three branches in China, according to U.S. officials
You may also be interested in...
U.S. FDA Commissioner Hamburg Promotes Regulatory Science Collaboration In China Visit
SHANGHAI - China is predicted to become the world's second largest economy by the end of this year, and last week, U.S. FDA Commissioner Margaret Hamburg made her first trip to China to boost communication with China's State FDA and to emphasize that the relationship between the U.S. and China has become more important than ever
U.S. FDA Commissioner Hamburg Promotes Regulatory Science Collaboration In China Visit
SHANGHAI - China is predicted to become the world's second largest economy by the end of this year, and last week, U.S. FDA Commissioner Margaret Hamburg made her first trip to China to boost communication with China's State FDA and to emphasize that the relationship between the U.S. and China has become more important than ever
U.S. FDA’s International Offices To Be Fully Staffed By End Of Summer
By the end of the summer, U.S. FDA will have a permanent staff in its newly opened international offices in China, Europe, India and Latin America